CARMA Study enrolled its first patients

We are glad to announce that the CARMA study has enrolled its first patients in Hospital 12 de Octubre in Madrid, Spain on Thursday the 7th of September.

The study has already been submitted in UK and Italy and approvals are awaited soon.

Thanks to the whole CARMA team for its great effort!

CARMA study approved in Spain!

We are please to report that CARMA has received approval from the Ethics Committee in Spain. This multi-centre, cross-sectional study of children with perinatally acquired HIV-1 on sustained suppressive antiretroviral therapy started before 2 years of age will start enrolling in the next few weeks. Submissions in Italy and the UK are ongoing and expected soon.

2nd Epiical Management Board

The second Epiical Management Board will be held in the island of San Servolo in Venice in conjunction with the PENTA Investigators Meeting 2017.

Looking forward to meeting all the members of the Board!

ViiV Healthcare press release

Today ViiV Healtcare announced the collaboration with the PENTA Foundation to provide dedicated funding for PENTA’s EPIICAL [1]Consortium in the quest to develop optimal treatment strategies for children living with HIV and explore the potential for achieving disease remission.

Click here to read the press release

 

 

 

Kick-Off Meeting Epiical Project

The Kick-Off meeting took place in Rome on 11th – 12th February 2016.
The Pontifical Urbaniana University held two intensive days of presentations and discussions.

Epiical Consortium

Presentations from the meeting can be found in the private area after logging in.